Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Feb 12;7(11):12904–12916. doi: 10.18632/oncotarget.7354

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2016 Puchades-Carrasco et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

OPLS-DA score plots for the comparisons between: A. healthy individuals () vs. NSCLC patients (early-stage and advanced-stage, and , respectively); B. healthy individuals () vs. early-stage NSCLC patients (); C. healthy individuals () vs. advanced-stage NSCLC patients () and D. early-stage NSCLC patients () vs. advanced-stage NSCLC patients (). SUS-plots derived from the OPLS-DA models between: E. healthy individuals vs. early-stage NSCLC patients (model B, horizontal axis) and healthy individuals vs. advanced-stage NSCLC patients (model C, vertical axis); F. healthy individuals vs. NSCLC patients (model A, horizontal axis) and early-stage NSCLC vs. advanced-stage NSCLC patients (model D, vertical axis). Rectangles indicate unique biomarkers for each model.

Inline graphic — OPLS-DA score plots for the comparisons between: A. healthy individuals () vs. NSCLC patients (early-stage and advanced-stage, and , respectively); B. healthy individuals () vs. early-stage NSCLC patients (); C. healthy individuals () vs. advanced-stage NSCLC patients () and D. early-stage NSCLC patients () vs. advanced-stage NSCLC patients (). SUS-plots derived from the OPLS-DA models between: E. healthy individuals vs. early-stage NSCLC patients (model B, horizontal axis) and healthy individuals vs. advanced-stage NSCLC patients (model C, vertical axis); F. healthy individuals vs. NSCLC patients (model A, horizontal axis) and early-stage NSCLC vs. advanced-stage NSCLC patients (model D, vertical axis). Rectangles indicate unique biomarkers for each model.